Cx43/NF-κB Pathway Drives AngII-Induced Macrophage M1 Polari
2026-05-23
This study elucidates how Angiotensin II (AngII) promotes M1-type polarization in RAW264.7 macrophages via the connexin 43 (Cx43)/NF-κB signaling axis. The research provides mechanistic evidence that selective inhibition of Cx43 hemichannels attenuates pro-inflammatory responses, offering new insights for neuroinflammation and atherosclerosis models.
RNAi Screening Reveals Vesicular Transport in SARS-CoV-2 Rel
2026-05-22
Kerr et al. conducted a comprehensive RNA interference (RNAi) screen to identify human host factors involved in SARS-CoV-2 replication, with a focus on the late stages of viral assembly and release. The study's identification of vesicle-mediated exocytic transport, particularly Rab11a-dependent trafficking, as critical for viral egress offers new avenues for host-targeted antiviral strategies.
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Workflows
2026-05-22
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, specific fluorescence-based detection of goat IgG in immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA. This reagent is not suitable for applications using non-goat primary antibodies or for targets outside validated immunodetection workflows.
Monomethyl auristatin E (MMAE): Reliable Solutions for Cytot
2026-05-21
This article delivers scenario-driven, evidence-backed guidance for biomedical researchers using Monomethyl auristatin E (MMAE, SKU A3631) in cell viability, proliferation, and cytotoxicity workflows. Practical Q&A blocks address real laboratory challenges, emphasizing reproducibility, data interpretation, and vendor selection, with direct links to protocols and critical references.
Ethacridine Lactate Monohydrate: Antiseptic Agent for Resear
2026-05-21
Ethacridine lactate monohydrate is a high-purity antiseptic compound derived from 7-ethoxyacridine-3,9-diamine, widely used for microbial inhibition in biochemical and cellular assays. Its robust solubility and mechanism of action make it essential for maintaining assay fidelity in sensitive workflows. APExBIO supplies this compound for research applications, not clinical use.
CFTRinh-172: Precision CFTR Inhibitor for Epithelial Researc
2026-05-20
CFTRinh-172 delivers rapid, selective CFTR inhibition for dissecting chloride channel dynamics in cystic fibrosis and secretory diarrhea models. This guide integrates protocol-ready workflows, troubleshooting strategies, and the latest mechanistic insights—empowering researchers to refine epithelial assay design and interpretation.
P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via Ca2+/CaM
2026-05-20
Li et al. (2025) reveal that P2RX1 overexpression enhances mitochondrial apoptosis in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) by modulating calcium signaling and suppressing PI3K/Akt activity. This mechanistic insight highlights P2RX1 as a potential target to overcome tyrosine kinase inhibitor resistance in Ph+ ALL.
Prostaglandin E2: A Translational Gatekeeper in Immunity and
2026-05-19
This thought-leadership article explores the multifaceted role of Prostaglandin E2 (PGE2) in immune regulation, inflammation research, and translational workflows. We bridge mechanistic insights with actionable strategies for experimentalists, referencing both peer-reviewed findings and competitive research solutions. Special emphasis is placed on how APExBIO's Prostaglandin E2 offering enables reproducibility and discovery, and how new evidence on lipid mediators is reshaping immunological intervention strategies.
Vincristine Sulfate in Cancer Research: Protocols and Troubl
2026-05-19
Vincristine sulfate is a cornerstone in experimental oncology, renowned for its precision in disrupting microtubule dynamics. This guide details actionable workflows, protocol enhancements, and troubleshooting strategies, empowering researchers to harness the full potential of vincristine for reproducible, high-impact cancer research.
Dorsomorphin (Compound C): Selective AMPK and BMP Pathway In
2026-05-18
Dorsomorphin (Compound C) is a potent, ATP-competitive AMPK inhibitor with high selectivity and dual action on BMP signaling. It is widely used for dissecting metabolic, autophagic, and differentiation pathways in cell and animal models. This article details its mechanisms, key applications, and evidence base.
LY364947 and the Future of TGF-β Pathway Modulation in Trans
2026-05-18
This article explores how LY364947, a potent TGF-β type I receptor kinase inhibitor, empowers translational researchers to decode and modulate the TGF-β/Smad signaling axis. By weaving together mechanistic insights, recent advances in epithelial-mesenchymal transition (EMT) inhibition, and strategic guidance, it distinguishes itself from conventional product pages. Anchored in both experimental and competitive context, the discussion highlights LY364947's unique role—from in vitro assay optimization to translational innovation in fibrosis, oncology, and retinal degeneration research—while also situating it within the evolving preclinical landscape.
Poly-GA-Induced Tau Phosphorylation via ERK1/2 in C9orf72 FT
2026-05-17
This study reveals that poly-glycine-alanine (poly-GA) dipeptide repeats associated with C9orf72 mutations drive tau hyperphosphorylation and neuronal death by directly activating ERK1/2 signaling in cellular models. The findings highlight ERK1/2 as a mechanistic link between C9orf72 pathology and tau aggregation, and demonstrate that selective MEK1/2 inhibition can mitigate these neurodegenerative processes.
SR-202 for PPARγ Antagonism: Precision Tools in Metabolic Re
2026-05-16
SR-202, a selective PPARγ antagonist, unlocks precise control over adipocyte differentiation and immunometabolic signaling pathways. Its high solubility, specificity, and robust in vitro and in vivo profiles make it indispensable for insulin resistance, obesity, and inflammation research.
Bufuralol Hydrochloride in Advanced Cardiovascular Research
2026-05-15
Bufuralol hydrochloride empowers cardiovascular pharmacology and β-adrenergic modulation studies with its unique partial agonist profile. This article details optimized workflows, integration with hiPSC-derived organoid models, and troubleshooting strategies for reproducible, human-relevant results.
Berberine Modulates RXRα/PPARγ/NEDD4 to Suppress SASP in Ath
2026-05-15
The referenced study uncovers that berberine attenuates senescence-associated secretory phenotype (SASP)–driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 axis. These mechanistic insights highlight a novel, targeted approach for modulating vascular aging and provide a clear framework for researchers dissecting PPARγ-mediated signaling in chronic inflammatory disease.
508 records 21/34 page Previous Next First page 上5页 2122232425 下5页 Last page